Sustained, New, Never, and Discontinued Tobacco Cessation Services Adopters

Overview

Journal J Subst Abuse Treat

Specialty Psychiatry

Date 2014 Sep 3

PMID 25178991

Citations 8

Authors

Lillian T Eby

Tanja C Laschober

Jessica L Muilenburg

Affiliations

Soon will be listed here.

Abstract

This study examined longitudinal adoption patterns of tobacco cessation (TC) counseling and TC pharmacotherapy in substance use disorder treatment programs and baseline predictors (program characteristics and program culture) of these patterns 12-months later. Telephone survey data were collected in 2010 from 685 randomly sampled program administrators working in geographically representative treatment programs across the U.S. Regarding TC counseling, about 41% of programs never adopt, 33% sustain, and 27% change adoption patterns. Concerning TC pharmacotherapy, about 62% of programs never adopt, 19% sustain, and 18% change adoption patterns. The three most consistent predictors of counseling adoption patterns are TC reimbursement, TC financial resource availability, and smoking culture. For TC pharmacotherapy adoption patterns, the most consistent predictors include profit status, TC reimbursement, level of care, TC financial resource availability, and smoking culture. Findings provide insights into program characteristics and program culture as both potential barriers and facilitators of longitudinal TCS adoption.

Citing Articles

Implementing tobacco-free policy in residential substance use disorders treatment: Practice changes among staff.

Campbell B, Le T, McCuistian C, Hosakote S, Kapiteni K, Guydish J Drug Alcohol Depend Rep. 2023; 2:100033.

PMID: 36845887 PMC: 9948912. DOI: 10.1016/j.dadr.2022.100033.

Smoking Intervention Practices in Texas Healthcare Centers with Sexual and Gender Minority Patients.

Taing M, Le K, Britton M, Chen T, Parent M, Tami-Maury I Health Behav Policy Rev. 2023; 9(6):1074-1088.

PMID: 36778530 PMC: 9910434. DOI: 10.14485/hbpr.9.6.1.

Implementation and Outcomes of a Comprehensive Tobacco Free Workplace Program in Opioid Treatment Centers.

Taing M, Nitturi V, Chen T, Kyburz B, Martinez Leal I, Correa-Fernandez V Int J Environ Res Public Health. 2022; 19(1).

PMID: 35010499 PMC: 8744608. DOI: 10.3390/ijerph19010239.

Addressing Smoking Cessation among Women in Substance Use Treatment: A Qualitative Approach to Guiding Tailored Interventions.

Martinez Leal I, Taing M, Correa-Fernandez V, Obasi E, Kyburz B, Le K Int J Environ Res Public Health. 2021; 18(11).

PMID: 34072064 PMC: 8198796. DOI: 10.3390/ijerph18115764.

Achieving Smoking Cessation Among Persons with Opioid Use Disorder.

Vlad C, Arnsten J, Nahvi S CNS Drugs. 2020; 34(4):367-387.

PMID: 32107731 PMC: 7609040. DOI: 10.1007/s40263-020-00701-z.

References

Rieckmann T, Kovas A, McFarland B, Abraham A . A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment. J Subst Abuse Treat. 2011; 41(4):374-85. PMC: 3486698. DOI: 10.1016/j.jsat.2011.05.005. View

Hurt R, Croghan I, Offord K, Eberman K, Morse R . Attitudes toward nicotine dependence among chemical dependence unit staff--before and after a smoking cessation trial. J Subst Abuse Treat. 1995; 12(4):247-52. DOI: 10.1016/0740-5472(95)00024-y. View

Richter K, Ahluwalia H, Mosier M, Nazir N, Ahluwalia J . A population-based study of cigarette smoking among illicit drug users in the United States. Addiction. 2002; 97(7):861-9. DOI: 10.1046/j.1360-0443.2002.00162.x. View

Knudsen H, Studts J . Availability of nicotine replacement therapy in substance use disorder treatment: longitudinal patterns of adoption, sustainability, and discontinuation. Drug Alcohol Depend. 2011; 118(2-3):244-50. PMC: 3150224. DOI: 10.1016/j.drugalcdep.2011.03.028. View

Muilenburg J, Laschober T, Eby L . Climate for innovation, 12-step orientation, and tobacco cessation treatment. J Subst Abuse Treat. 2013; 46(4):447-55. PMC: 3943819. DOI: 10.1016/j.jsat.2013.10.016. View

Guydish J, Passalacqua E, Tajima B, Chan M, Chun J, Bostrom A . Smoking prevalence in addiction treatment: a review. Nicotine Tob Res. 2011; 13(6):401-11. PMC: 3103720. DOI: 10.1093/ntr/ntr048. View

Klein K, Conn A, Sorra J . Implementing computerized technology: an organizational analysis. J Appl Psychol. 2001; 86(5):811-24. DOI: 10.1037/0021-9010.86.5.811. View

Williams S, Hafner J, Morton D, Holm A, Milberger S, Koss R . The adoption of smoke-free hospital campuses in the United States. Tob Control. 2009; 18(6):451-8. DOI: 10.1136/tc.2009.030494. View

Knudsen H, Studts J, Boyd S, Roman P . Structural and cultural barriers to the adoption of smoking cessation services in addiction treatment organizations. J Addict Dis. 2010; 29(3):294-305. PMC: 2922688. DOI: 10.1080/10550887.2010.489446. View

10.

Muilenburg J, Laschober T, Eby L . Organizational factors as predictors of tobacco cessation pharmacotherapy adoption in addiction treatment programs. J Addict Med. 2013; 8(1):59-65. PMC: 4000618. DOI: 10.1097/ADM.0000000000000008. View

11.

Friedmann P, Jiang L, Richter K . Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United States. J Subst Abuse Treat. 2007; 34(2):165-72. PMC: 3689419. DOI: 10.1016/j.jsat.2007.02.006. View

12.

Hurt R, Offord K, Croghan I, Kottke T, Morse R, Melton 3rd L . Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA. 1996; 275(14):1097-103. DOI: 10.1001/jama.275.14.1097. View

13.

Hays J, Schroeder D, Offord K, Croghan I, Patten C, Hurt R . Response to nicotine dependence treatment in smokers with current and past alcohol problems. Ann Behav Med. 2000; 21(3):244-50. DOI: 10.1007/BF02884841. View

14.

Ziedonis D, Guydish J, Williams J, Steinberg M, Foulds J . Barriers and solutions to addressing tobacco dependence in addiction treatment programs. Alcohol Res Health. 2007; 29(3):228-35. PMC: 6527042. View

15.

Knudsen H, Ducharme L, Roman P, Link T . Buprenorphine diffusion: the attitudes of substance abuse treatment counselors. J Subst Abuse Treat. 2005; 29(2):95-106. DOI: 10.1016/j.jsat.2005.05.002. View

16.

Richter K, Arnsten J . A rationale and model for addressing tobacco dependence in substance abuse treatment. Subst Abuse Treat Prev Policy. 2006; 1:23. PMC: 1560115. DOI: 10.1186/1747-597X-1-23. View

17.

Rothrauff T, Eby L . Counselors' knowledge of the adoption of tobacco cessation medications in substance abuse treatment programs. Am J Addict. 2010; 20(1):56-62. PMC: 3677156. DOI: 10.1111/j.1521-0391.2010.00095.x. View

18.

Morgenstern J, Blanchard K, Morgan T, Labouvie E, Hayaki J . Testing the effectiveness of cognitive-behavioral treatment for substance abuse in a community setting: within treatment and posttreatment findings. J Consult Clin Psychol. 2002; 69(6):1007-17. DOI: 10.1037//0022-006x.69.6.1007. View

19.

Knudsen H, Muilenburg J, Eby L . Sustainment of smoking cessation programs in substance use disorder treatment organizations. Nicotine Tob Res. 2012; 15(6):1060-8. PMC: 3646650. DOI: 10.1093/ntr/nts242. View

20.

Hughes J, Novy P, Hatsukami D, Jensen J, Callas P . Efficacy of nicotine patch in smokers with a history of alcoholism. Alcohol Clin Exp Res. 2003; 27(6):946-54. DOI: 10.1097/01.ALC.0000071742.86555.4D. View